Anixa stockholders re-elect four directors, approve exec compensation, ratify auditor at 2022 annual meeting

Anixa Biosciences Inc

Re-elected directors Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. with between 8.4M and 9.2M votes for.
Non-binding advisory vote on executive compensation approved: 6,670,331 for, 2,450,849 against, 188,009 abstain, 9,914,423 broker non-votes.
Ratified appointment of Haskell & White LLP as auditor for FY ending Oct 31, 2022: 19,035,845 for, 193,874 against, 83,893 abstain.
Total shares present at meeting: 19,313,612 of 30,132,319 outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.